Common Contracts
9 similar Change in Control Agreement contracts by Regenerx Biopharmaceuticals Inc
Amended and Restated Change in Control AgreementChange in Control Agreement • August 14th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
This Amended and Restated Change in Control Agreement (this “Agreement”) is effective as of July 2, 2012, by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and J.J. Finkelstein (the “Executive”).
Amended and Restated Change in Control AgreementChange in Control Agreement • August 14th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
This Amended and Restated Change in Control Agreement (this “Agreement”) is effective as of July 2, 2012, by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Dr. Allan L. Goldstein (the “Executive”).
Amended and Restated Change in Control AgreementChange in Control Agreement • August 14th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
This Amended and Restated Change in Control Agreement (this “Agreement”) is effective as of July 2, 2012, by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and David R. Crockford (the “Executive”).
AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • May 15th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Agreement”) is effective as of April 3 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DAVID R. CROCKFORD (the “Executive”).
AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • May 15th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Agreement”) is effective as of April 3, 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DR. ALLAN L. GOLDSTEIN (the “Executive”).
AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • May 15th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Agreement”) is effective as of April 3, 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and J.J. FINKELSTEIN (the “Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • January 6th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”) is made and entered into effective as of January 1, 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DAVID R. CROCKFORD (the “Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • January 6th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”) is made and entered into effective as of January 1, 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and J.J. FINKELSTEIN (the “Executive”).
CHANGE IN CONTROL AGREEMENTChange in Control Agreement • January 6th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”) is made and entered into effective as of January 1, 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DR. ALLAN L. GOLDSTEIN (the “Executive”).
